AIG
SPRY icon

American International Group’s ARS Pharmaceuticals SPRY Stock Holding History

American International Group’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,099
Closed -$124K – 2348
2024
Q1 		$124K Sell
12,099
-103
-0.8% -$768 ﹤0.01% 2400
2023
Q4 		$66.9K Buy
12,202
+101
+0.8% +$442 ﹤0.01% 2743
2023
Q3 		$45.7K Buy
12,101
+429
+4% +$2.82K ﹤0.01% 2839
2023
Q2 		$78.2K Buy
+11,672
New +$77.9K ﹤0.01% 2721
2022
Q2 		– Sell
-10,182
Closed -$36K – 3252
2022
Q1 		$36K Sell
10,182
-716
-7% -$3.12K ﹤0.01% 2943
2021
Q4 		$73K Sell
10,898
-326
-3% -$2.65K ﹤0.01% 2842
2021
Q3 		$112K Buy
11,224
+4,096
+57% +$101K ﹤0.01% 2760
2021
Q2 		$220 Sell
7,128
-265
-4% -$8.5K ﹤0.01% 2455
2021
Q1 		$323 Buy
+7,393
New +$350K ﹤0.01% 2091

Other funds holding SPRY

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American International Group's SPRY Position: Q2 2024 in Review

American International Group sold out of ARS Pharmaceuticals (SPRY) in Q2 2024, closing a stake of 12,099 shares — an estimated $124K sold.

American International Group first reported a position in SPRY in Q1 2021 and held it in 9 quarters. The position peaked at $124K in Q1 2024. 115 funds tracked by Wall St. Rank hold SPRY as of Q2 2024.

  • American International Group reported no remaining ARS Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 12,099 ARS Pharmaceuticals shares in Q2 2024, an estimated $124K.
  • American International Group first reported a position in ARS Pharmaceuticals in Q1 2021 and held it in 9 quarters.
  • American International Group's ARS Pharmaceuticals position peaked at $124K in Q1 2024.
  • 115 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.